List of bibliographic references
Number of relevant bibliographic references: 4.
List of associated KwdEn.i
Nombre de documents | Descripteur |
2 | Antineoplastic Agents (therapeutic use) |
2 | Breast Neoplasms (drug therapy) |
2 | Female |
2 | Humans |
2 | Receptor, ErbB-2 (genetics) |
2 | Receptor, ErbB-2 (metabolism) |
1 | Adult |
1 | Antibodies, Monoclonal, Humanized (therapeutic use) |
1 | Breast Neoplasms (enzymology) |
1 | Breast Neoplasms (genetics) |
1 | Breast Neoplasms (metabolism) |
1 | Breast Neoplasms (pathology) |
1 | Carcinoma (drug therapy) |
1 | Carcinoma (metabolism) |
1 | Centromere |
1 | Chemotherapy, Adjuvant |
1 | Chromosomes, Human, Pair 17 |
1 | Disease-Free Survival |
1 | Estrogen Receptor alpha (genetics) |
1 | Estrogen Receptor alpha (metabolism) |
1 | Gene Amplification |
1 | Gene Dosage |
1 | Genetic Heterogeneity |
1 | Genetic Predisposition to Disease |
1 | Immunohistochemistry |
1 | In Situ Hybridization |
1 | In Situ Hybridization, Fluorescence |
1 | Middle Aged |
1 | Multivariate Analysis |
1 | Patient Selection |
1 | Phenotype |
1 | Precision Medicine |
1 | Predictive Value of Tests |
1 | Prognosis |
1 | Proportional Hazards Models |
1 | Protein Kinase Inhibitors (therapeutic use) |
1 | RNA, Messenger (metabolism) |
1 | Randomized Controlled Trials as Topic |
1 | Receptor, ErbB-2 (antagonists & inhibitors) |
1 | Trastuzumab |
1 | Trastuzumab (therapeutic use) |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Giuseppe Viale"
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i \
-Sk "Giuseppe Viale" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Allemagne
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Giuseppe Viale
}}
| This area was generated with Dilib version V0.6.33. Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 | |